APA (7th ed.) Citation

Abdul-Ghani, M., Al Jobori, H., Daniele, G., Adams, J., Cersosimo, E., Triplitt, C., & DeFronzo, R. A. (2017). Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose. Diabetes (New York, N.Y.), 66(9), 2495-2502. https://doi.org/10.2337/db17-0055

Chicago Style (17th ed.) Citation

Abdul-Ghani, Muhammad, Hussein Al Jobori, Giuseppe Daniele, John Adams, Eugenio Cersosimo, Curtis Triplitt, and Ralph A. DeFronzo. "Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose." Diabetes (New York, N.Y.) 66, no. 9 (2017): 2495-2502. https://doi.org/10.2337/db17-0055.

MLA (9th ed.) Citation

Abdul-Ghani, Muhammad, et al. "Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose." Diabetes (New York, N.Y.), vol. 66, no. 9, 2017, pp. 2495-2502, https://doi.org/10.2337/db17-0055.